Infusion-related reactions to infliximab (remicade®) in patients with rheumatoid arthritis:: Relationship to dose, anti-histamine pre-treatment and infusion number

被引：0
|
作者：
Wasserman, MJ [1 ]
Weber, DA [1 ]
Guthrie, JA [1 ]
Mitroi, E [1 ]
Bykerk, V [1 ]
Lee, P [1 ]
Keystone, EC [1 ]
机构：
[1] Univ Toronto, Mt Sinai Hosp, Ctr Adv Therapeut, Toronto, ON M5G 1X5, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2003年 / 30卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1888 / 1888
页数：1
相关论文
共 50 条
  • [21] Oral Glucocorticoid Premedication Is at Least as Effective as Intravenous Glucocorticoid Premedication for Prevention of Infusion-related Reactions to Rituximab in Rheumatoid Arthritis Patients
    Bovens, Pauline
    Van Esveld, Luuk
    Wientjes, Maike
    van Herwaarden, Noortje
    Ten Cate, David
    Melis, Eward
    Lesuis, Nienke
    van den Bemt, Bart
    den Broeder, Alfons
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1085 - 1087
  • [22] Development of antibodies against infliximab during infliximab treatment in rheumatoid arthritis. Relation to infusion reactions and treatment response.
    Kapetanovic, MC
    Geborek, P
    Saxne, T
    Larsson, L
    Kristensen, LE
    Svenson, M
    Bendtzen, K
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S543 - S543
  • [23] Safety of Infliximab Treatment in Patients with Rheumatoid Arthritis in a Real-world Clinical Setting: Description and Evaluation of Infusion Reactions
    Kelsall, John
    Rogers, Pamela
    Galindo, Griselda
    De Vera, Mary A.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1539 - 1545
  • [24] Utilizing a novel four-drug regimen to reduce the incidence of infusion-related reactions for first-dose rituximab infusions: An institutional review of rituximab infusion-related reactions in lymphoma patients.
    Bartels, Trace
    Moore, Logan
    Persky, Daniel Oscar
    Kumar, Abhijeet
    Abraham, Ivo
    McBride, Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Management of infusion reactions to infliximab in patients with rheumatoid arthritis or spondyloarthritis:: Experience from an immunotherapy unit of rheumatology
    Lequerre, Thierry
    Vittecoq, Olivier
    Klemmer, Nathalie
    Goeb, Vincent
    Pouplin, Sophie
    Menard, Jean-Francois
    Daragon, Alain
    Mejjad, Othmane
    Le Loet, Xavier
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (07) : 1307 - 1314
  • [26] Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis
    Augustsson, Jenny
    Eksborg, Staffan
    Ernestam, Sofia
    Gullstrom, Eleanor
    van Vollenhoven, Ronald
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (11) : 1462 - 1466
  • [27] The Presence of Anti-Rituximab Antibodies Predicts Infusion-Related Reactions in Patients with Systemic Lupus Erythematosus
    Wincup, Chris
    Menon, Madhvi
    Smith, Edward
    Isenberg, David A.
    Jury, Elizabeth
    Mauri, Claudia
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [28] CORRELATION OF INFUSION-RELATED REACTIONS (IRR) AND OUTCOME IN PATIENTS RECEIVING NGR-HTNF TREATMENT
    Rossoni, G.
    Gregorc, V.
    Bulotta, A.
    Vigano, M. G.
    Todisco, G.
    Lambiase, A.
    Bordignon, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 167 - 167
  • [29] Patients with infusion-related reactions on fixed-dose rituximab treatment have higher body surface area than those without infusion-related reactions in adults with frequently relapsing minimal change nephrotic syndrome: a retrospective study
    Nishiura, Hironobu
    Takahashi, Masaya
    Mori, Katsuhito
    Sugimoto, Takashi
    Emoto, Masanori
    Nakamura, Yasutaka
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2024, 10 (01)
  • [30] Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus
    Wincup, Chris
    Menon, Madhvi
    Smith, Edward
    Schwartz, Ann
    Isenberg, David
    Jury, Elizabeth C.
    Mauri, Claudia
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (08) : 1140 - +
12345